AmatoABaldassanoSLiottaRSerioRMulF
The reason I say this is because with Triumph-1 Eli Lilly only had the raw trial data for a couple weeks, so they scrambled to pull out the stuff thats relevant to a conference such as this meaning any deeper exploration on the liver and kidney were left out
A complete PA submission typically includes: Patient demographics, current BMI with date of measurement, weight history showing chronicity, qualifying comorbidities with ICD-10 codes, documented prior weight-loss attempts and outcomes, prior pharmacotherapy trials and reasons for failure or intolerance, the prescriber's clinical rationale for the requested medication, and contraindications to alternative therapies if relevant
Thats why at Hormone Replacement Therapy LA, we focus on understanding your needs and helping you discover solutions tailored specifically for your body and lifestyle
This is interesting as danuglipron was the only compound capable of engaging mGs in the endoplasmic reticulum